Pheochromocytoma Market is Growing at a Permissive CAGR of 3.84% During Forecast 2019-2025
Market Highlights Pheochromocytoma is a catecholamine-secreting rare type of adrenal gland tumor. In this condition, the adrenal gland produces excess amounts of norepinephrine and epinephrine hormones, hence elevating the blood pressure and heart rate. According to MRFR analysis, the global Pheochromocytoma Market is expected to register a CAGR of 3.84% during the forecast period of 2019 to 2025 . The global market was valued at USD 2,814.75 million in 2018. The global pheochromocytoma market is growing owing to the increasing investment by major companies to develop specific treatment options, high prevalence of pheochromocytoma, and increasing number of clinical trials for drugs for pheochromocytoma. Furthermore, the rapidly changing lifestyle, rising healthcare expenditure, and increasing incidence rate of rare tumors are also expected to fuel the market growth. However, the stringent government regulations, lack of availability of specific drugs and lack of awareness r...